Unveiling the BMI Risk Threshold for Osteoarthritis: Multi‐Database Causal and Nonlinear Evidence
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Shaohong Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijin…. Hauptthemen laut MEDLINE: Body Mass Index, Osteoarthritis, Obesity. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fujian Provincial Health Technology Project, Science and Technology Innovation Startup Fund of Fujian Maternal and Child Health Care Hospital.
Abstract (Originalsprache)
Objective
To characterize the nonlinear relationship between BMI and osteoarthritis (OA), and to identify BMI thresholds that inform precise prevention strategies.
Methods
This multi‐database study integrated Global burden of disease 2021, National Health and Nutrition Examination Survey 2007–2018, and Genome‐Wide Association Studies. A generalized additive model was performed to visualize the BMI‐OA relationship, adjusting for multiple confounders. We applied segmented logistic regression models to identify potential threshold effects and used Mendelian randomization to estimate the causal effects of BMI on OA subtypes.
Results
From 1990 to 2021, the age‐standardized prevalence and years lived with disability rates for OA were highest in regions with high SDI. OA prevalence rose nonlinearly with BMI, with breakpoints at 24.00 and 41.58 kg/m 2 . Each unit increase in BMI was associated with higher odds of OA between 24.00 and 41.58 kg/m 2 (OR = 1.022, 95% CI: 1.003–1.041) and above 41.58 kg/m 2 (OR = 1.055, 95% CI: 1.022–1.090). Women and individuals aged ≥ 45 years exhibited a higher susceptibility to knee osteoarthritis. BMI was causally associated with knee osteoarthritis (OR = 1.63, 95% CI 1.50–1.77) and hip osteoarthritis (OR = 1.54, 95% CI 1.40–1.70).
Conclusions
These findings suggest that OA risk awareness and weight‐management strategies should begin before BMI reaches the high range, particularly among individuals with BMI exceeding 24.00 kg/m 2 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
- Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- The School of Public Health, Fujian Medical University, Fuzhou, China.
- "The 14th Five-Year Plan" Application Characteristic Discipline of Hunan Province (Clinical Medicine), Changsha Medical University, Changsha, China.
- National Institute of Health Data Science of China, Jinan, China.
- Faculty of Social Sciences and Humanities, Mahidol University, Bangkok, Thailand.
ORCID-Profile: Shaohong Yu, Xiuquan Lin
Förderung
- Fujian Provincial Health Technology Project
- Science and Technology Innovation Startup Fund of Fujian Maternal and Child Health Care Hospital
Zitieren
APA
Yu, S., Zeng, L., Yang, L., Ou, Y., Yang, C., Lin, X., Shao, J., Guan, Q., Li, G., & Lin, X. (2026). Unveiling the BMI Risk Threshold for Osteoarthritis: Multi‐Database Causal and Nonlinear Evidence. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70892
Vancouver
Yu S, Zeng L, Yang L, Ou Y, Yang C, Lin X, et al. Unveiling the BMI Risk Threshold for Osteoarthritis: Multi‐Database Causal and Nonlinear Evidence. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70892
BibTeX
@article{Yu2026,
author = {Yu, Shaohong and Zeng, Li and Yang, Lei and Ou, Yangjiang and Yang, Chenglin and Lin, Xiaoru and Shao, Jingyi and Guan, Qing and Li, Guobo and Lin, Xiuquan},
title = {Unveiling the BMI Risk Threshold for Osteoarthritis: Multi‐Database Causal and Nonlinear Evidence},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70892}
}
EUVIMED